insights_auto
Why is GH down 2,87%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
US$180,00
arrow_downward
-2,87%(-5,31) 1D
30 ຕ.ລ., 10 ໂມງ 15 ນາທີ 25 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$182,48
High
US$185,64
Low
US$179,90
Mkt. cap
24,16 ຕື້
Avg. vol.
1,86 ລ້ານ
Volume
102,28 ພັນ
52-wk high
US$191,05
52-wk low
US$74,55
EPS
US$-3,50
Beta
1,58
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
Open
US$182,48
High
US$185,64
Low
US$179,90
Mkt. cap
24,16 ຕື້
Avg. vol.
1,86 ລ້ານ
Volume
102,28 ພັນ
52-wk high
US$191,05
52-wk low
US$74,55
EPS
US$-3,50
Beta
1,58
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Investing.com
·
14 ຊົ່ວໂມງກ່ອນ
Guardant Health options signal 14% stock move on earnings
Zacks
·
1 ມື້ກ່ອນ
Guardant Health (GH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Investing.com
·
3 ມື້ກ່ອນ
BTIG raises Guardant Health stock price target on growth outlook
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 ພັນ
Founded2012
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth care provider
Websiteguardanthealth.com